Use of combined oral contraceptives for the management of heavy menstrual bleeding

References

• Fraser IS, Critchley HO, Munro MG, Broder M; Writing group for this menstrual agreement process. A process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding. Fertil. Steril.87, 466–476 (2007).
   PubMed Web of Science ®Google Scholar
• Hallberg L, Hogdahl A, Nilsson L, Rybo G. Menstrual blood loss – a population study. Acta. Obstet. Gynecol. Scand.45, 320–351 (1996).
   Web of Science ®Google Scholar
• Barnard K, Frayne SM, Skinner KM, Sullivan LM. Health status among women with menstrual symptoms. J. Womens Health (Larchmt)12, 911–919 (2003).
   PubMed Web of Science ®Google Scholar
• Cote I, Jacobs P, Cumming D. Work loss associated with increased menstrual loss in the United States. Obstet. Gynecol.100, 683–687 (2002).
   PubMed Web of Science ®Google Scholar
• Wu JM, Wechter ME, Geller EJ, Nguyen TV, Visco AG. Hysterectomy rates in the United States, 2003. Obstet. Gynecol.110, 1091–1095 (2007).
   PubMed Web of Science ®Google Scholar
• Whiteman MK, Hillis SD, Jamieson DJ et al. Inpatient hysterectomy surveillance in the United States, 2000–2004. Am. J. Obstet. Gynecol.198, 34.e1–e7 (2008).
   PubMed Web of Science ®Google Scholar
• Kuppermann M, Varner RE, Summitt RL Jr et al. Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning: the medicine or surgery (Ms) randomized trial. JAMA291, 1447–1455 (2004).
   PubMed Web of Science ®Google Scholar
• Vessey MP, Villard-Mackintosh L, McPherson K, Coulter A, Yeates D. The epidemiology of hysterectomy: findings in a large cohort study. Br. J. Obstet. Gynaecol.99, 402–407 (1992).
   PubMedGoogle Scholar
• Lethaby A, Shepperd S, Cooke I, Farquhar C. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database Syst. Rev.2, CD000329 (2000).
   Google Scholar
• Kucuk T, Ertan K. Continuous oral or intramuscular medroxyprogesterone acetate versus the levonorgestrel releasing intrauterine system in the treatment of perimenopausal menorrhagia: a randomized, prospective, controlled clinical trial in female smokers. Clin. Exp. Obstet. Gynecol.35, 57–60 (2008).
   PubMed Web of Science ®Google Scholar
• Kaunitz A, Bissonnette F, Monteiro I, Lukkari-Lax E, Muysers C, Jensen JT. Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial. Obstet. Gynecol.116, 625–632 (2010); erratum in: Obstet. Gynecol.116, 999 (2010).
   PubMed Web of Science ®Google Scholar
• Middleton LJ, Champaneria R, Daniels JP et al. Hysterectomy, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding: systematic review and meta-analysis of data from individual patients. Br. Med. J.341, c3929 (2010).
   Web of Science ®Google Scholar
• Blumenthal PD, Dawson L, Hurskainen R. Cost–effectiveness and quality of life associated with heavy menstrual bleeding among women using the levonorgestrel-releasing intrauterine system. Int. J. Gynecol. Obstet.12, 171–178 (2011).
   Web of Science ®Google Scholar
• Abbott JA, Garry R. The surgical management of menorrhagia. Hum. Reprod. Update8, 68–78 (2002).
   PubMed Web of Science ®Google Scholar
• Nieboer TE, Johnson N, Lethaby A et al. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst. Rev.8, CD003677 (2009).
   Google Scholar
• Hurskkainen Cooper R, Mishra G, Hardy R, Kuh D. Hysterectomy and subsequent psychological health: findings from a British birth cohort study. J. Affect. Disord.115, 122–130 (2009).
   PubMed Web of Science ®Google Scholar
• Farquhar C, Brown J. Oral contraceptive pill for heavy menstrual bleeding. Cochrane Database Syst. Rev.7, CD000154 (2009).
   Google Scholar
• Fraser IS, McCarron G. Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia. Aust. NZ J. Obstet. Gynaecol.31, 66–70 (1991).
   PubMed Web of Science ®Google Scholar
• Nilsson L, Rybo G. Treatment of menorrhagia. Am. J. Obstet. Gynecol.110, 713–720 (1971).
   PubMed Web of Science ®Google Scholar
• Jensen JT, Parke S, Mellinger U, Machlitt A, Fraser IS. Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial. Obstet. Gynecol.117, 777–787 (2011).
   PubMed Web of Science ®Google Scholar
• Ahrendt HJ, Makalova D, Parke S, Mellinger U, Mansour D. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel. Contraception80, 436–444 (2009).
   PubMed Web of Science ®Google Scholar
• Mishell DR Jr. Noncontraceptive benefits of oral contraceptives. J. Reprod. Med.38(Suppl. 12), 1021–1029 (1993).
   PubMed Web of Science ®Google Scholar
• Shabaan MM, Zakherah MS, El-Nashar SA, Sayed GA. Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: a randomized clinical trial. Contraception83, 48–54 (2011).
   PubMed Web of Science ®Google Scholar
• Endrikat J, Shapiro H, Lukkari-Lax E, Kunz M, Schmidt W, Fortier M. A Canadian, multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia. J. Obstet. Gynaecol. Can.31, 340–347 (2009).
   PubMedGoogle Scholar
• Lethaby AE, Cooke I, Rees M. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst. Rev.4, CD002126 (2005).
   PubMedGoogle Scholar
• Irvine GA, Campbell-Brown MB, Lumsden MA, Heikkila A, Walker JJ, Cameron IT. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. Br. J. Obstet. Gynaecol.105, 592–598 (1998).
   PubMedGoogle Scholar
• Sasagawa S, Shimizu Y, Kami H et al. Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile. Steroids73, 222–231 (2008).
   PubMed Web of Science ®Google Scholar